Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Sep 20 2023

Full Issue

Viewpoints: Covid Isn't Over For Everyone; Should Humans Create And Use An Artificial Womb?

Editorial writers delve into covid, artificial wombs, DBT, and more.

The Washington Post: For The Immunocompromised, Covid Isn’t ‘Over.’ It’s Complicated

Myelodysplastic syndrome, or high-risk myelodysplastic syndrome, the official diagnosis my husband had received that spring (“high risk of dying,” as I tended to clarify), has complicated the already complicated notion of a “post-pandemic” world for me. (Esme Weijun Wang, 9/20)

The Boston Globe: The Controversial Birth Of The Artificial Womb

The Food and Drug Administration has convened a Pediatric Advisory Committee this week to determine whether artificial womb technology is ready to try on premature infants as well as to address regulatory and ethical considerations. Although the technology is promising, this development poses numerous ethical challenges. (Arthur Caplan and Gwendolyn P. Quinn, 9/19)

The Washington Post: Dialectical Behavior Therapy Could Save Lives From Suicide 

In the 1980s, when Anthony DuBose set out to become a psychologist, he was told never to work with people with borderline personality disorder because they had high rates of suicide and intense emotional distress. They were considered untreatable. (Kate Woodsome, 9/20)

Chicago Tribune: Cut To VA Funding For Ambulances Would Harm Our Nation’s Veterans

Unless stopped, the Department of Veterans Affairs is set to knock over a domino that may drastically harm veterans’ health care and then spread to the general community. (William Enyart, 9/19)

Stat: How Value-Based Payments Are Straining Access To Primary Care

Difficulty scheduling an urgent or time-sensitive appointment is now the most common gripe my patients sound off about to my primary care colleagues and me. Our practice is not the exception — it has become the rule. A 2022 national survey showed that, on average, it takes 20.6 days to get a family medicine appointment. (Jeffrey Millstein, 9/20)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, June 9
  • Monday, June 8
  • Friday, June 5
  • Thursday, June 4
  • Wednesday, June 3
  • Tuesday, June 2
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF